Related Experiment Video

Updated: Jun 21, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Adenoma development in a patient with MUTYH-associated polyposis (MAP): new insights into the natural course of polyp

Markus Casper1, Guido Plotz, Bernhard Juengling

  • 1Department of Internal Medicine II, Saarland University Hospital, Kirrberger Strasse, Homburg/Saar, Germany. inmcas@uks.eu

Digestive Diseases and Sciences
|August 13, 2009
PubMed
Abstract

Insights

MUTYH-associated polyposis (MAP) is a genetic condition linked to MUTYH gene mutations. This case study shows adenoma development accelerates in a patient

Area of Science:

  • Genetics
  • Gastroenterology
  • Oncology

Background:

  • Biallelic germ-line mutations in the MUTYH gene predispose individuals to MUTYH-associated polyposis (MAP).
  • MAP patients exhibit diverse clinical presentations, with limited data on disease progression.

Observation:

  • A 14-year colonoscopic surveillance of an MAP patient (p.Y165C/p.G382D) revealed slow adenoma development post-colorectal cancer diagnosis at age 44.
  • A significant increase in annual adenoma development was observed in the patient's early fifties.

Findings:

  • The natural history of MAP can involve a delayed but substantial acceleration in polyp development.
  • This accelerated polypogenesis may contribute to the wide phenotypic variability observed in newly diagnosed MAP patients.

Implications:

  • MAP should be considered in younger individuals (35-55 years) presenting with colorectal cancer or fewer adenomas.
  • Further research is needed to confirm accelerated adenoma-to-carcinoma progression in MAP, suggested by high-grade dysplasia in small adenomas.

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...